Samsung Bioepis Launches OPUVIZTM (Aflibercept) 40 mg/mL Vial Across Europe, to Treat Ophthalmic Conditions

INCHEON, Korea--(BUSINESS WIRE)-- #Europe--Samsung Bioepis launches Opuviz (aflibercept) in Europe.